{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:22:01Z","timestamp":1787829721650,"version":"build-2784847793"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,29]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>To explore the efficacy and mechanism of Buzhong Yiqi Decoction (BZYQD) in the treatment of gastric cancer (GC) using meta-analysis and network pharmacology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We searched PubMed, Embase, Cochrane Library, Chinese BioMedical Literature Database, China National Knowledge Infrastructure, China Science and Technology Journal (CQVIP), and Wanfang databases for randomized controlled trials that evaluated BZYQD therapy for GC. The outcomes were clinical efficacy, 2-year survival rate, Karnofsky performance status score, and incidence of adverse reactions. We performed a meta-analysis using RevMan 5.3 software. Then, the potential active ingredients and targets of BZYQD were screened through the Traditional Chinese Medicine Systems Pharmacology. GC-related targets were screened through the GeneCards database. The \u201cactive ingredients-targets\u201d network was constructed by Cytoscape 3.8.0 software, and the protein\u2013protein interaction network was constructed using the STRING database. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses of the effective targets of BZYQD in GC were performed through the Metascape platform. Finally, molecular docking technology was used to identify the affinity and activity between core targets and active compounds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 15 randomized controlled trials were included in the literature. This literature included a total of 1176 patients, of whom 588 were in the treatment group and 588 were in the control group. In terms of efficacy indicators and incidence of adverse reactions, the treatment group was better than the control group. There was a statistical difference (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). A total of 150 active ingredients of BZYQD and 136 targets acting on GC were identified. A total of 2430 Gene Ontology terms and 172 Kyoto Encyclopedia of Genes and Genomes enrichment entries were obtained using enrichment analysis, involving apoptosis and the phosphoinositide 3-kinase\/protein kinase B signaling pathway. The high affinity and activity of the core targets and active compounds were verified through molecular docking.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study demonstrated the efficacy and safety of BZYQD in the treatment of GC, and the related molecular mechanisms were initially revealed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049076","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:07:42Z","timestamp":1780074462000},"page":"e49076","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of the efficacy and mechanism of action of Buzhong Yiqi Decoction on gastric cancer using meta-analysis and network pharmacology"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7421-1594","authenticated-orcid":false,"given":"Ruiping","family":"Yang","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggui","family":"Wu","sequence":"additional","affiliation":[{"name":"Basic Medical Sciences College, Hubei University of Chinese Medicine, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Tao","sequence":"additional","affiliation":[{"name":"Clinical School of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Lin","sequence":"additional","affiliation":[{"name":"Basic Medical Sciences College, Hubei University of Chinese Medicine, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Jiang","sequence":"additional","affiliation":[{"name":"Basic Medical Sciences College, Hubei University of Chinese Medicine, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260827","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260827","first-page":"26","article-title":"Epidemiology of gastric cancer: global trends, risk factors and prevention.","volume":"14","author":"Rawla","year":"2019","journal-title":"Prz Gastroenterol"},{"key":"R3-20260827","first-page":"1032","article-title":"Comparison the incidence and severity of side effects profile of FOLFOX and DCF regimens in gastric cancer patients.","volume":"18","author":"Salehifar","year":"2019","journal-title":"Iran J Pharm Res"},{"key":"R4-20260827","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jep.2014.06.012","article-title":"Prescription patterns of Chinese herbal products for post-surgery colon cancer patients in Taiwan.","volume":"155","author":"Chao","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"R5-20260827","doi-asserted-by":"crossref","first-page":"104623","DOI":"10.1016\/j.phrs.2019.104623","article-title":"Modified Bu-Zhong-Yi-Qi decoction synergies with 5 fluorouracile to inhibits gastric cancer progress via PD-1\/PD- L1-dependent T cell immunization.","volume":"152","author":"Xu","year":"2020","journal-title":"Pharmacol Res"},{"key":"R6-20260827","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","article-title":"Meta-analysis: principles and procedures.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R7-20260827","first-page":"2556521","article-title":"Network pharmacology and molecular docking analysis on the pharmacological mechanisms of modified Sanmiaosan in treating ulcerative colitis.","volume":"2022","author":"Wang","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"R8-20260827","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jebm.12141","article-title":"The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review.","volume":"8","author":"Zeng","year":"2015","journal-title":"J Evid Based Med"},{"key":"R9-20260827","doi-asserted-by":"crossref","first-page":"19496","DOI":"10.1038\/s41598-021-98925-6","article-title":"Network pharmacology-based investigation of potential targets of Astragalus membranaceous-Angelica sinensis compound acting on diabetic nephropathy.","volume":"11","author":"Dong","year":"2021","journal-title":"Sci Rep"},{"key":"R10-20260827","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines.","volume":"6","author":"Ru","year":"2014","journal-title":"J Cheminform"},{"key":"R11-20260827","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/nar\/gky092","article-title":"UniProt: the universal protein knowledgebase.","volume":"46","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"R12-20260827","doi-asserted-by":"crossref","first-page":"baw030","DOI":"10.1093\/database\/baw030","article-title":"Genic insights from integrated human proteomics in GeneCards.","volume":"2016","author":"Fishilevich","year":"2016","journal-title":"Database (Oxford)"},{"key":"R13-20260827","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R14-20260827","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.compbiolchem.2015.08.008","article-title":"Core and peripheral connectivity based cluster analysis over PPI network.","volume":"59","author":"Ahmed","year":"2015","journal-title":"Comput Biol Chem"},{"key":"R15-20260827","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"R16-20260827","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases.","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"R17-20260827","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank.","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"R18-20260827","first-page":"426","article-title":"Effects of Buzhong Yiqi decoction combined with XELOX regimen on short-term efficacy and long-term survival rate in advanced gastric cancer.","volume":"15","author":"Hou","year":"2020","journal-title":"World Chin Med"},{"key":"R19-20260827","first-page":"29","article-title":"Analysis of clinical value of Buzhong Yiqi decoction in the treatment of cancer-related fatigue during chemotherapy of gastric cancer.","volume":"1","author":"Fan","year":"2022","journal-title":"J Diet Health"},{"key":"R20-20260827","first-page":"525","article-title":"Efficacy of Buzhong Yiqi decoction combined with capecitabine and oxaliplatin in the treatment of advanced gastric cancer.","volume":"27","author":"Wang","year":"2020","journal-title":"Chin J Clin Oncol Rehabil"},{"key":"R21-20260827","first-page":"89","article-title":"Effect of Buzhong Yiqi decoction combined with conventional chemotherapy on short-term efficacy and incidence of adverse reactions in patients with gastric cancer after radical gastrectomy.","volume":"34","author":"Bai","year":"2021","journal-title":"J Qiannan Med Coll Natl"},{"key":"R22-20260827","first-page":"995","article-title":"Modified Buzhong Yiqi decoction combined with chemotherapy in the treatment of 50 cases of postoperative gastric cancer.","volume":"8","author":"Meng","year":"2015","journal-title":"Glob Tradit Chin Med"},{"key":"R23-20260827","first-page":"79","article-title":"Clinical study on Buzhong Yiqi Tang for postoperative patients with gastric cancer.","volume":"51","author":"Zheng","year":"2019","journal-title":"J New Chin Med"},{"key":"R24-20260827","first-page":"37","article-title":"Effect of modified Buzhong Yiqi decoction on gastrointestinal function recovery of Qi deficiency and blood stasis syndrome after gastric cancer operation.","volume":"31","author":"Gao","year":"2019","journal-title":"Tianjin Pharm"},{"key":"R25-20260827","first-page":"215","article-title":"Effect of Buzhong Yiqi decoction on the recovery of Qi deficiency and blood stasis syndrome gastrointestinal function after gastric cancer.","volume":"33","author":"Song","year":"2018","journal-title":"Guangming J Chin Med"},{"key":"R26-20260827","first-page":"61","article-title":"Efficacy analysis of modified Buzhong Yiqi decoction combined with chemotherapy in the treatment of postoperative patients with gastric cancer.","volume":"15","author":"Liu","year":"2018","journal-title":"J North Pharm"},{"key":"R27-20260827","first-page":"39","article-title":"Clinical observation of Buzhong Yiqi decoction combined with SOX therapy on the patient with advanced gastric cancer.","volume":"26","author":"Qin","year":"2012","journal-title":"J Pract Tradit Chin Intern Med"},{"key":"R28-20260827","first-page":"3160","article-title":"Effects of Buzhong Yiqi decoction on Th1, Th2 cytokines and Th1\/Th2 immune balance in patients with gastric cancer.","volume":"35","author":"Pei","year":"2020","journal-title":"China J Tradit Chin Med Pharm"},{"key":"R29-20260827","first-page":"2308","article-title":"Efficacy and safety of modified Buzhong Yiqi decoction on patients with spleen and stomach Qi deficiency syndrome after gastric cancer chemotherapy.","volume":"16","author":"Sun","year":"2021","journal-title":"World J Integr Tradit Western Med"},{"key":"R30-20260827","first-page":"4160","article-title":"Effect of Buzhong Yiqi decoction combined with XELOX in the treatment of advanced gastric cancer.","volume":"30","author":"Chen","year":"2021","journal-title":"Henan Med Res"},{"key":"R31-20260827","first-page":"185","article-title":"Efficacy of Buzhong Yiqi decoction modified traditional Chinese medicine oral adjuvant chemotherapy on postoperative patients with gastric cancer.","volume":"10","author":"Xu","year":"2016","journal-title":"World Clin Med"},{"key":"R32-20260827","first-page":"3455","article-title":"Effect of Buzhong Yiqi decoction on cancer-related fatigue and quality of life in patients with advanced gastric cancer.","volume":"17","author":"Xie","year":"2020","journal-title":"Lab Med Clin"},{"key":"R33-20260827","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.21037\/apm-21-1469","article-title":"Integration of network pharmacology and molecular docking technology reveals the mechanism of the herbal pairing of Codonopsis Pilosula (Franch.) Nannf and Astragalus Membranaceus (Fisch.) Bge on chronic heart failure.","volume":"10","author":"Xu","year":"2021","journal-title":"Ann Palliat Med"},{"key":"R34-20260827","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/s41598-021-81485-0","article-title":"Study of the active ingredients and mechanism of Sparganii rhizoma in gastric cancer based on HPLC-Q-TOF-MS\/MS and network pharmacology.","volume":"11","author":"Lu","year":"2021","journal-title":"Sci Rep"},{"key":"R35-20260827","first-page":"4803","article-title":"The effect of quercetin on the malignant behavior of gastric cancer cells by regulating p53 expression.","volume":"41","author":"Shao","year":"2021","journal-title":"Chin J Gerontol"},{"key":"R36-20260827","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3892\/ijmm.2016.2625","article-title":"Quercetin inhibits the growth of human gastric cancer stem cells by inducing mitochondrial-dependent apoptosis through the inhibition of PI3K\/Akt signaling.","volume":"38","author":"Shen","year":"2016","journal-title":"Int J Mol Med"},{"key":"R37-20260827","first-page":"12","article-title":"Quercetin affects leptin and its receptor in human gastric cancer MGC-803 cells and JAK-STAT pathway.","volume":"28","author":"Qin","year":"2012","journal-title":"Chin J Cell Mol Immunol"},{"key":"R38-20260827","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3892\/or.2014.3662","article-title":"Kaempferol inhibits gastric cancer tumor growth: an in vitro and in vivo study.","volume":"33","author":"Song","year":"2015","journal-title":"Oncol Rep"},{"key":"R39-20260827","first-page":"1270","article-title":"The effect of kaempferol on PARP1 and P53 genes expression in gastric cancer cells.","volume":"39","author":"Wang","year":"2020","journal-title":"Genom Appl Biol"},{"key":"R40-20260827","first-page":"3099","article-title":"Study on the mechanism of nobiletin inhibiting the invasiveness of SGC-7901 gastric cancer cells.","volume":"28","author":"Yang","year":"2020","journal-title":"Mod Oncol"},{"key":"R41-20260827","doi-asserted-by":"crossref","first-page":"11365","DOI":"10.1007\/s13277-016-5013-2","article-title":"Naringenin inhibits proliferation, migration, and invasion as well as induces apoptosis of gastric cancer SGC7901 cell line by downregulation of AKT pathway.","volume":"37","author":"Bao","year":"2016","journal-title":"Tumour Biol"},{"key":"R42-20260827","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3892\/etm.2015.2912","article-title":"Enhanced anticancer effect of ABT-737 in combination with naringenin on gastric cancer cells.","volume":"11","author":"Zhang","year":"2016","journal-title":"Exp Ther Med"},{"key":"R43-20260827","first-page":"589","article-title":"Study on apoptosis mechanism of gastric cancer cell line MGC-803 induced by formononetin.","volume":"23","author":"Liu","year":"2020","journal-title":"Chin J Curr Adv Gen Surg"},{"key":"R44-20260827","doi-asserted-by":"crossref","first-page":"101042831771462","DOI":"10.1177\/1010428317714626","article-title":"Progress in the treatment of advanced gastric cancer.","volume":"39","author":"Song","year":"2017","journal-title":"Tumour Biol"},{"key":"R45-20260827","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12029-017-9997-7","article-title":"A comprehensive review on pharmacotherapeutics of three phytochemicals, curcumin, quercetin, and allicin, in the treatment of gastric cancer.","volume":"48","author":"Haghi","year":"2017","journal-title":"J Gastrointest Cancer"},{"key":"R46-20260827","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41419-018-0930-1","article-title":"Kaempferol induces autophagic cell death via IRE1-JNK-CHOP pathway and inhibition of G9a in gastric cancer cells.","volume":"9","author":"Kim","year":"2018","journal-title":"Cell Death Dis"},{"key":"R47-20260827","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3390\/molecules21070914","article-title":"Nobiletin induces protective autophagy accompanied by ER-stress mediated apoptosis in human gastric cancer SNU-16 cells.","volume":"21","author":"Moon","year":"2016","journal-title":"Molecules"},{"key":"R48-20260827","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s10637-019-00767-7","article-title":"Discovery and anticancer evaluation of a formononetin derivative against gastric cancer SGC7901 cells.","volume":"37","author":"Yao","year":"2019","journal-title":"Invest New Drugs"},{"key":"R49-20260827","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/ijc.21170","article-title":"Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer.","volume":"117","author":"Oki","year":"2005","journal-title":"Int J Cancer"},{"key":"R50-20260827","first-page":"126","article-title":"STAT3 pathway in gastric cancer: signaling, therapeutic targeting and future prospects.","volume":"9","author":"Ashrafizadeh","year":"2020","journal-title":"Biology (Basel)"},{"key":"R51-20260827","doi-asserted-by":"crossref","first-page":"12016","DOI":"10.18632\/oncotarget.2434","article-title":"Role of p53 in the progression of gastric cancer.","volume":"5","author":"Busuttil","year":"2014","journal-title":"Oncotarget"},{"key":"R52-20260827","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.lfs.2011.11.017","article-title":"Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease.","volume":"90","author":"Wancket","year":"2012","journal-title":"Life Sci"},{"key":"R53-20260827","doi-asserted-by":"crossref","first-page":"109585","DOI":"10.1016\/j.biopha.2019.109585","article-title":"Ginkgolic acid (GA) suppresses gastric cancer growth by inducing apoptosis and suppressing STAT3\/JAK2 signaling regulated by ROS.","volume":"125","author":"Liang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"R54-20260827","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3390\/nu10081043","article-title":"Pectolinarigenin induced cell cycle arrest, autophagy, and apoptosis in gastric cancer cell via PI3K\/AKT\/mTOR signaling pathway.","volume":"10","author":"Lee","year":"2018","journal-title":"Nutrients"},{"key":"R55-20260827","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12079-009-0066-2","article-title":"The matricellular functions of small leucine-rich proteoglycans (SLRPs).","volume":"3","author":"Merline","year":"2009","journal-title":"J Cell Commun Signal"},{"key":"R56-20260827","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3389\/fimmu.2020.00718","article-title":"The emerging role of the IL-17B\/IL-17RB pathway in cancer.","volume":"11","author":"Bastid","year":"2020","journal-title":"Front Immunol"},{"key":"R57-20260827","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1172\/JCI64115","article-title":"TNF signaling drives myeloid-derived suppressor cell accumulation.","volume":"122","author":"Zhao","year":"2012","journal-title":"J Clin Invest"},{"key":"R58-20260827","doi-asserted-by":"crossref","first-page":"3","DOI":"10.31083\/2019.8674","article-title":"Targeting HIF-1alpha signaling pathway for gastric cancer treatment.","volume":"74","author":"Li","year":"2019","journal-title":"Pharmazie"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:00:48Z","timestamp":1787828448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":58,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049076","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"2025-01-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}